LOS ANGELES--(BUSINESS WIRE)--Several newly released scientific findings focusing on various aspects of Proxcelan™ (Cesium-131) seeds’ effectiveness in the treatment of prostate cancer -- supporting and broadening the growing body of evidence on the newest medical isotope being used in permanent seed therapy.
